Department of Bioengineering and Therapeutic Sciences

The right dose: how pharmacy researchers are making medicine more precise

Reprinted courtesy of UCSF Magazine.

In the pediatric bone marrow transplant clinic, pharmacist Janel Boyle’s past and present collide.

She drifts past young patients—many of them infants and toddlers—and notes their beaming smiles and balding heads. Her gaze shifts to the parents, their...

Nevan Krogan, PhD

QBI Director and Professor

As director of the Quantitative Biosciences Institute (QBI), I aim to create a framework that fosters open collaboration between scientists locally, domestically, and internationally, where each group brings something unique but highly complementary to the problem. At the onset of the current...

Abate honored by World Economic Forum at meeting in China

Faculty member Adam Abate, PhD, was selected by the World Economic Forum (WEF) as one of 45 exceptional Young Scientists—all under the age of 40—each of whom has contributed to advancing the frontiers of science, engineering, or technology in areas of high societal impact.

Department says farewell to Brodsky

The Department of Bioengineering and Therapeutic Sciences bade a fond farewell to colleague and friend Frances Brodsky on Tuesday, November 10, 2015. At a royal-tea-party-themed send-off, Frances was toasted and feted with fond wishes and thanks for 28 years of dedicated service to UCSF.

Giacomini to lead largest study of genetic, ethnic differences in effectiveness of leading diabetes drug

In people with type 2 diabetes, the body is less able to use the hormone insulin to regulate blood sugar. The disease affects 350 million patients globally—including 29 million in the United States, where it is the leading cause of blindness, kidney failure, and non-accident-related amputations.

Pages